Blocking IL-1α but not IL-1β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice

Vaccine

Volumn 29, Issue 6, 2011, Pages 1339-1346

  Guler, Reto ^a   Parihar, Suraj P ^a   Spohn, Gunther ^b   Johansen, Pål ^c   Brombacher, Frank ^a   Bachmann, Martin F ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b CYTOS BIOTECHNOLOGY AG   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Autoantibodies; Immunization; Infection; Interleukin 1; Mycobacterium tuberculosis; Virus like particle

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS PARTICLE; WEIGHT GAIN;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 78751578879     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.045     Document Type: Article

References (32)

1. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002, 13(4-5):323-340.
2. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87(6):2095-2147.
3. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
4. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010, 10(2):89-102.
5. Dayer J.M. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2003, 42(Suppl. 2):ii3-ii10.
6. Spohn G., Keller I., Beck M., Grest P., Jennings G.T., Bachmann M.F. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur J Immunol 2008, 38(3):877-887.
7. Yamada H., Mizumo S., Horai R., Iwakura Y., Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab Invest 2000, 80(5):759-767.
8. Fremond C.M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol 2007, 179(2):1178-1189.
9. Juffermans N.P., Florquin S., Camoglio L., Verbon A., Kolk A.H., Speelman P., et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000, 182(3):902-908.
10. Denis M., Ghadirian E. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect Immun 1994, 62(2):457-461.
11. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 1996, 19(5):177-181.
12. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., et al. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta. IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998, 187(9):1463-1475.
13. Zheng H., Fletcher D., Kozak W., Jiang M., Hofmann K.J., Conn C.A., et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 1995, 3(1):9-19.
14. Glaccum M.B., Stocking K.L., Charrier K., Smith J.L., Willis C.R., Maliszewski C., et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 1997, 159(7):3364-3371.
15. Labow M., Shuster D., Zetterstrom M., Nunes P., Terry R., Cullinan E.B., et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 1997, 159(5):2452-2461.
16. Rothstein J.L., Johnson D., DeLoia J.A., Skowronski J., Solter D., Knowles B. Gene expression during preimplantation mouse development. Genes Dev 1992, 6(7):1190-1201.
17. McCune R.M., Tompsett R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 1956, 104(5):737-762.
18. Jegerlehner A., Tissot A., Lechner F., Sebbel P., Erdmann I., Kundig T., et al. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 2002, 20(25-26):3104-3112.
19. Spohn G., Guler R., Johansen P., Keller I., Jacobs M., Beck M., et al. A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis. J Immunol 2007, 178(11):7450-7457.
20. Flynn J.L., Scanga C.A., Tanaka K.E., Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998, 160(4):1796-1803.
21. Havell E.A., Moldawer L.L., Helfgott D., Kilian P.L., Sehgal P.B. Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol 1992, 148(5):1486-1492.
22. Hirsch E., Irikura V.M., Paul S.M., Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996, 93(20):11008-11013.
23. Irikura V.M., Hirsch E., Hirsh D. Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes. Infect Immun 1999, 67(4):1901-1909.
24. Chensue S.W., Warmington K.S., Berger A.E., Tracey D.E. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. Am J Pathol 1992, 140(2):269-275.
25. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., et al. Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 2010, 184(7):3326-3330.
26. Kafka D., Ling E., Feldman G., Benharroch D., Voronov E., Givon-Lavi N., et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol 2008, 20(9):1139-1146.
27. Voronov E., Dotan S., Gayvoronsky L., White R.M., Cohen I., Krelin Y., et al. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice. Int Immunol 2010, 22(4):245-257.
28. Vonk A.G., Netea M.G., van Krieken J.H., Iwakura Y., van der Meer J.W., Kullberg B.J. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J Infect Dis 2006, 193(10):1419-1426.
29. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001, 167(12):6957-6966.
30. Hernandez-Pando R., Orozco H., Arriaga K., Sampieri A., Larriva-Sahd J., Madrid-Marina V. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 1997, 90(4):607-617.
31. van der Deen M., Timens W., Timmer-Bosscha H., van der Strate B.W., Scheper R.J., Postma D.S., et al. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res 2007, 8:49.
32. Sone S., Okubo A., Ogura T. Normal human alveolar macrophages have more ability than blood monocytes to produce cell-associated interleukin-1-alpha. Am J Respir Cell Mol Biol 1989, 1(6):507-515.